?您的位置:對照品 > 標準品 > 分析標準品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:D495325 |
| 產(chǎn)品名稱:(2E)-N-[3,4-Dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylam |
| 產(chǎn)品CAS:1456696-14-2 |
| 規(guī)格含量:10mg |
| 產(chǎn)品價格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
D495325 |
| 名稱: |
(2E)-N-[3,4-Dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide |
| 別名: |
Afatinib Impurity J |
| CAS號: |
1456696-14-2 |
| 分子式: |
C??H??N?O? |
| 分子量: |
358.39 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
(2E)-N-[3,4-Dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide, s an impurity of Afatinib (A355300), an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder. |
| 參考文獻 |
|
|
|
|
|
|